Thompson Siegel & Walmsley LLC Charles River Laboratories International, Inc. Transaction History
Thompson Siegel & Walmsley LLC
- $6.19 Billion
- Q3 2025
A detailed history of Thompson Siegel & Walmsley LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 36,605 shares of CRL stock, worth $6.14 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
36,605
Previous 40,293
9.15%
Holding current value
$6.14 Million
Previous $6.11 Million
6.33%
% of portfolio
0.09%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
644Shares Held
51.7MCall Options Held
201KPut Options Held
179K-
Vanguard Group Inc Valley Forge, PA5.84MShares$980 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$854 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.19MShares$535 Million0.09% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$365 Million0.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$307 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.54B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...